Adrian Hill

Adrian Hill is the Lakshmi Mittal Professor of Vaccinology and Director of the Jenner Institute at the University of Oxford. He leads research on vaccines for malaria and other major diseases, with a focus on genetic susceptibility to infection and vaccine delivery technologies.

• Key Achievements: Founded the Jenner Institute in 2005, which now operates clinical-stage vaccine programs against fifteen diseases.
• Notable Work: Developed the R21 malaria vaccine with matrix-M adjuvant, showing high efficacy in clinical trials (Lancet, 2021).
• Global Impact: Spearheaded Oxford's rapid response to the COVID-19 pandemic, resulting in the AstraZeneca vaccine.

Research Focus: Malaria vaccine development, human genetics in infectious disease susceptibility, and innovative immunization strategies. His work bridges clinical trials, tropical medicine, and translational research.

Scientific Leadership: Recognized through fellowships at the Royal Society, Royal College of Physicians, and Academy of Medical Sciences. He has published over 600 papers with 60,000 citations and co-founded multiple spin-off companies.